AMT to appeal against gene therapy opinion
Amsterdam Molecular Therapeutics Holding NV is to appeal against a negative opinion issued by the European Medicines Agency for its gene therapy to treat a protein deficiency linked to pancreatitis. The opinion was issued on 23 June 2011.